Increased PrEP Uptake Could Lead to Significant Drop in New HIV Cases
Uptake in pre-exposure prophylaxis (PrEP) could significantly affect the rate of new HIV diagnoses, according to a recent study published in the Journal of Acquired Immune Deficiency Syndromes.
Can Fighting HIV Cause Cancer-Related Mutations?
Combatting viruses, such as HIV, may cause several enzymes in the immune system to malfunction and trigger cancer-related mutations, according a recently-published study in Nature Communications.
Almost Half of Cancer Cases, Cancer-Related Deaths Are Preventable
Nearly half of cancer cases and related deaths are preventable, according to data recently published by CA: A Cancer Journal of Clinicians.
Combining HIV Prevention Services Can Reduce New Infections
Using multiple prevention strategies for HIV can significantly reduce new infections.
FDA OKs Evolocumab Indication for CV Risk Reduction
The FDA has approved evolocumab (Repatha, Amgen) for the prevention of heart attacks, stroke, and coronary revascularizations in adult patients with already established cardiovascular disease.
Breast Cancer Risk Heightened by Diabetes in African American Women?
Type 2 diabetes may be linked to a heightened risk of developing breast cancer among African American women, according to a recently-published study.
Cancer Drug Costs on the Rise Despite Competition
Oncology drug prices are increasing, even when other competitors enter the market, according to a new study published by the Journal of Clinical Oncology.
UNAIDS: 21 Million HIV-Positive Patients on Antiretroviral Therapy
Nearly 21 million HIV-positive individuals are treated with antiretroviral therapy, according to a recently-published report by UNAIDS, indicating significant progress in treating HIV.
New Diagnostic Test May Improve Early Detection of Ovarian Cancer
A new blood test may improve accuracy of ovarian cancer diagnosis by detecting the cancer earlier and more accurately.
Novel Algorithm Addresses Challenges in Immunotherapy
A newly-developed mathematical model may be able to accurately predict whether a patient with cancer will respond to immunotherapy.
FDA Approves First Complete 2-Drug HIV Therapy
Officials with the FDA have approved the first complete 2-drug regimen for the treatment of patients with HIV-1.
Children with HIV Over Diagnosed with Asthma?
Pediatric patients with HIV may be over diagnosed with asthma, according to a recently-published study in The Journal of Allergy and Clinical Immunology.
Cancer Diagnosis Affects Heart Attack Treatment?
Patients with cancer who experienced a heart attack were more likely to die in the hospital compared with patients without cancer, according to the study.
Accessing Prescription Drugs During a Natural Disaster
Missing doses of necessary drugs can result in disease progression and poor health outcomes, according to the AARP.
Research Shows Sleep Influences Cancer Development
It is recommended that most adults receive 7 to 9 hours of sleep per night for optimal cognition and general well-being.
FDA Recalls Dietary Supplement GEC Laxpolex
Supplements found to contain anabolic steroids and steroid-like substances.
Novel Mouse Model Could Help Prevent Future Influenza Outbreaks
MxA acts as a shield against cross-species influenza A.
Influenza Diagnostic to Improve Patient Care
The diagnostic analyzer detects influenza at the point-of-care to provide a rapid diagnosis.
Could Stevia Play a Role in Diabetes Prevention?
Stevioside may be a cost-effective compound in the fight against diabetes.
Defective Pacemaker Has Caused Death, FDA Warns
Some St. Jude Medical pacemakers have been failing in patients as early as 24 hours after a low battery alert.
Caffeine Compound May Protect Against Parkinson's Disease
The caffeine-based compounds could prevent the misfolding of Î±-synuclein.
2 Clarke Drive Cranbury, NJ 08512